TABLE 4.
Genotype | No. of clinically TSE-affected animals/total no. of animals | Scrapie incubation period (dpi) (mean ± SD) | Death from intercurrent disease |
PrPSc accumulation (no. of goats/total no. examined) |
||
---|---|---|---|---|---|---|
No. of goats/total no. in group | Time to death (dpi) | CNS | Lymphoid tissuesb | |||
I142R154R211Q222/IRRQ (wild type) | 5/5 | 486 ± 21 | 5/5 | 5/5 | ||
M142RQ/IRRQ | 5/5 | 788 ± 99 | 5/5 | 5/5 | ||
IH154RQ/IRRQ | 5/5 | 624 ± 148 | 5/5 | 0/5 | ||
IRQ211Q/IRRQ | 5/5 | 1,291 ± 325 | 5/5 | 5/5 | ||
IRQ211Q/IRRQ211Q | 10/10 | 770 ± 139 | 10/10 | 1/10 | ||
IRRK222/IRRQ | 2/5 | 1,900, 2,174 | 3/5 | 568, 898, 1,062 | 2/5c | 0/5 |
IRRK222/IRRK222 | 1/5 | 2,101 | 1/1 | 0/1 |
Groups of five goats were intracerebrally challenged in the temporal cortex with the same classical scrapie isolate used for oral challenge. Animals that were still alive were at >2,400 days postinoculation at the time of writing.
Tonsils, prescapular lymph nodes, ileal/jejunal Peyer's patches, and mesenteric lymph nodes.
The two PrPSc-positive animals were clinically affected.